Adrenal steroidogenic cytochrome P450 enzymes

Adrenal steroidogenic cytochrome P450 enzymes are a specialized group of heme-containing monooxygenases located in the mitochondria and endoplasmic reticulum of the adrenal cortex [2, 3]. This family includes five primary enzymes: CYP11A1 (cholesterol side-chain cleavage), CYP17A1 (17α-hydroxylase/17,20-lyase), CYP21A2 (21-hydroxylase), CYP11B1 (11β-hydroxylase), and CYP11B2 (aldosterone synthase) [2, 3]. These enzymes catalyze the essential steps in the biosynthesis of mineralocorticoids, glucocorticoids, and adrenal androgens from cholesterol [2]. They are critical therapeutic targets for managing endocrine disorders characterized by hormone excess, such as Cushing's syndrome and primary aldosteronism, as well as hormone-dependent malignancies like advanced prostate cancer [3, 5]. Drugs targeting these enzymes, such as abiraterone and osilodrostat, work by competitively or irreversibly inhibiting specific enzymatic steps to lower systemic hormone levels [3, 5]. However, because these enzymes share structural similarities and operate in a complex network, pharmacological modulation often requires careful monitoring for adrenal insufficiency and off-target effects [5]. Common adverse effects include hypertension and hypokalemia resulting from the accumulation of steroid precursors like 11-deoxycorticosterone [5]. Understanding the distinct roles and regulatory mechanisms of each enzyme is vital for developing selective inhibitors with improved safety profiles [3].

Other names

Steroidogenic P450sAdrenal P450 enzymesSteroid hydroxylasesAdrenal steroidogenic enzymesCorticosteroidogenic enzymes

Competitive inhibition of the heme-binding site, irreversible inhibition of enzymatic activity, and modulation of electron transfer from redox partners leading to the blockade of steroid hormone biosynthesis pathways.